Neurological examination revealed disorientation, ocular abnormalities, weakness, sensory deficits, and preserved ankle jerks
The main outcomes for this study were: development of diabetic retinopathy (ICD-10 codes: E11.319, E11.329, E11.339, E11.349, E11.359, E11.352, E11.353, E11.354, E11.355) and DMO (ICD-10 codes: H35.81, E11.311, E11.321, E11.331, E11.341, E11.351)
In addition, the medication works to stimulate your pancreas to produce more insulin
Rapid weight loss often means skipping exercise due to low energy, resulting in muscle and water loss
Unraveling the Safety of Compounded Semaglutide In the realm of diabetes management, the quest for effective medications that balance efficacy with safety is an ongoing journey